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15 ABSTRACT 
16 Micro-estuarine ecosystems have a surface area < 1 km2 and are abundant in Mediterranean 
17 regions. As a result of their small size, these systems are particularly vulnerable to effects of 
18 chemical pollution. Due to fluctuating flow conditions of base-flow dominated by treated 
19 wastewater effluents and flood events transporting rural and urban non-point-source pollution, 
20 micro-estuaries are under a dynamic risk regime, consequently, struggling to provide 
21 ecological services. This two-year study explored the occurrence and risks of pharmaceutical 
22 contamination in the Alexander micro-estuary in Israel. Pharmaceuticals were detected in all 
23 samples (n=280) at as high as 18 µg L-1 in flood events and 14 µg L-1 in base-flow. 
24 Pharmaceutical mixtures composition was affected by flow conditions with carbamazepine 
25 dominating base-flow and caffeine dominating flood events. Median annual risk quotients for 
26 fish, crustaceans and algae were 19.6, 5.2, and 4.5, indicating that pharmaceuticals pose high 
27 risk to the ecosystem. Ibuprofen, carbamazepine and caffeine were contribute most to the risk 
28 quotients. The current work highlights that micro-estuary ecosystems, like the Alexander 
29 estuary, are continuously exposed to pharmaceuticals and most likely to other pollutants, 
30 placing these ecologically important systems under an elevated risk, in comparison to the more 
31 frequently studied large estuarine systems.  
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32 INTRODUCTION
33 Surface waters around the world are contaminated with and influenced by diverse mixtures 
34 of organic pollutants, such as solvents, microplastics, flame retardants, pesticides and 
35 pharmaceuticals1,2. Chronic exposure of stream and estuarine environments to active 
36 pharmaceuticals has become a global emerging ecological risk3. The main sources of 
37 pharmaceuticals in surface water include raw sewage or treated wastewater effluents4–6, urban 
38 runoff7, and runoff from arable land irrigated with treated wastewater or amended with 
39 biosolids or animal manures and slurries8. Due to water shortages, irrigation of agricultural 
40 systems with treated wastewater is becoming more prevalent, resulting in the ubiquitous 
41 presence of pharmaceuticals in runoff water7 and stream base flows9. 
42 Flow patterns of semi-arid streams are characterized by low-discharge base flows which 
43 are often dominated by, or mixed with effluents and flood events during the rainy season 
44 composed of both urban and agricultural runoff10,11. Such flow patterns are found in streams in 
45 the Mediterranean climate zone, which includes southeastern Spain12, southern Portugal13, 
46 northwestern China14, southern California15 and the Middle East16. The eastern zone of the 
47 Mediterranean Sea uses large amounts of treated wastewater for agricultural irrigation (87% in 
48 Israel17), increasing the probability of introducing chemicals, such as pharmaceuticals, into 
49 streams from cultivated fields during storm events. Thus, together with urban runoff and 
50 sewage overflow, stormwater flood events are a dominant contributor to pharmaceutical loads 
51 in streams7. While stormwater flow makes up a relatively small proportion, timewise, of the 
52 annual flow, it contributes a dominant fraction of the annual water volume11. Moreover, flood-
53 event frequency and magnitude are expected to increase in these regions due to climate 
54 change18. 
55 The presence of pharmaceuticals in both base flow and flood events results in chronic 
56 exposure of aquatic habitats to pharmaceutical mixtures with changing temporal dynamics. 
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57 These flow dynamics change further when entering transitional water bodies, such as lagoons, 
58 fjords and estuaries, where geochemical conditions and water residence time changes 
59 dramatically11. Estuaries, which are a zone of mixed surface and sea water19, are often 
60 characterized by longer water residence times and strong gradients of salinity, temperature and 
61 turbidity. These gradients are especially dynamic in micro-estuaries, which are typical to semi-
62 arid zones11.  These relatively small water bodies of few meters in depth, a few kilometers in 
63 length, and a surface area of <1 km2, are mainly governed by a sandbar at the mouth section. 
64 Despite their small size, micro-estuaries are an important ecological and sociological services 
65 provider11. These environments are generally understudied, and although they are known to 
66 frequently suffer from eutrophication11, little is known on the risk they are subjected to from 
67 micropollutants, such as pharmaceuticals, and on their ability to attenuate such toxicants as 
68 shown for other similar vegetated water bodies20.
69 The occurrence, composition and concentration dynamics of mixtures of pharmaceuticals 
70 pose a potential unacceptable risk to aquatic habitats. Although the potential risk of single 
71 pharmaceuticals to different aquatic compartments has been previously shown, evaluating risk 
72 for mixtures is more challenging21. Many tools and models exist for the determination of the 
73 risks of pollutant mixtures22, with the most effective for risk estimation being the concentration 
74 addition model22. Although this model neglects the possible antagonistic and synergistic 
75 interactions of chemicals, it can serve as an important tool for assessing mixture risk and 
76 identifying dominant pollutants and threatened taxonomic groups22.
77 For a comprehensive evaluation of potential risks of pharmaceuticals in micro-estuarine 
78 environments, flux dynamics must be quantified. This calls for high-temporal-resolution 
79 sampling combined with comprehensive analytical analysis and the application of appropriate 
80 risk models. The current study explored the biannual dynamics of pharmaceutical mixture 
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81 fluxes in and out of the micro-estuary and evaluates the risk posed by the pharmaceuticals to 
82 aquatic organisms.
83
84 MATERIALS AND METHODS 
85 Site and sampling 
86 The Alexander stream main channel flows a distance of 32 km and drains an area of 550 
87 km2. It starts in the Samaria mountains (Palestinian Territory), crosses the Hefer valley (Israel), 
88 and ends at the Mediterranean Sea (Figure S1). The Alexander stream is ephemeral throughout 
89 most of its length, receiving some fountain water and mainly treated wastewater from a 
90 treatment facility located ~13 km upstream from the estuary head. The Alexander estuary 
91 (defined as a micro-estuary11) is ~6.5 km long with a maximal depth of ~3 m and average cross-
92 sectional width of 20 m. Detailed characteristics of the Alexander micro-estuary are described 
93 elsewhere11,23,24. Water upstream from the estuary head (N32.375 E34.912) and adjacent to the 
94 estuary mouth (N32.394 E34.869) was sampled at the depth of ~20 cm (Figure S1). Each of 
95 the sampling stations was equipped with an automated water sampler (Sigma 900©, Hach 
96 Company, Loveland CO; and ISCO 3700 Full-Size Portable Sampler, Teledyne, Lincoln NE) 
97 with a carousel containing 24 350mL glass bottles. Samples were taken every 0.25–4 h, with 
98 higher sampling frequency during the rising limb of the hydrograph and peak discharge, and 
99 lower sampling frequency on the falling limb of the hydrograph. Monthly base-flow water grab 
100 samples were collected with a horizontal water sampler (5 L, Model 110B, OceanTest 
101 Equipment, Fort Lauderdale FL). All samples were filtered using 90 mm GF/F filters (nominal 
102 pore size of 0.7 µm, MGF, Sartorius, Göttingen, Germany) and immediately frozen (-20 C). 
103 A total of 237 flood samples and 44 base-flow samples were analyzed over 2 hydrological 
104 years (2016–2018). 
105
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106 Analysis of pharmaceuticals 
107 Water samples were defrosted overnight and 200-mL aliquots were spiked with 10 µL of a 
108 mixture of isotopically labeled internal standards (see detailed information in SI) and 
109 concentrated using SPE cartridges (Strata-X, 200 mg, Phenomenex, Torrance, CA). 
110 Pharmaceuticals were quantified by LC–HRMS analysis using a Q Exactive Plus hybrid FT 
111 mass spectrometer coupled with a Dionex Ultimate 3000 RS UPLC (Thermo Fisher Scientific, 
112 Waltham, MA). Instrumental parameters, limits of quantification are recoveries are shown in 
113 the SI and in Table S1. 
114
115 Ecotoxicological risks: Single-compounds 
116 Experimental data on the apical effects (72 h algal growth; 21 d daphnid reproduction, 28 
117 d fish growth and reproduction etc.) of the studied compounds were obtained from the 
118 published literature. The values were then used alongside assessment factors proposed by the 
119 European Chemicals Agency25 (Table S2) to derive predicted no-effect concentrations for the 
120 aquatic habitat (PNECaquatic) (Table 1 and Table S3)25. In the case where only genotoxicity tests 
121 results were available, no assessment factors were applied due to the sensitivity of such 
122 experiments. Risk characterization ratios for each study compound for each sample monitored 
123 were then calculated using Equation 1. A risk quotient (RQ) ≥1 was considered an unacceptable 
124 risk for the aquatic habitat. RQs were calculated based on a single-compound approach:
125 (1)𝑅𝑄𝑝= 𝑀𝐶𝑃𝑁𝐸𝐶𝑎𝑞𝑢𝑎𝑡𝑖𝑐
126 where RQp is the pharmaceutical RQ, and MC is the measured concentration of the 
127 pharmaceutical.
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128 Ecotoxicological risks: Pharmaceutical mixtures 
129 RQs were also calculated for the mixture of the studied compounds in each sample. It would 
130 be inappropriate to use a mixture of endpoints for different taxonomic groups to assess the risk 
131 of the mixtures. Therefore, we initially estimated PNECs for each pharmaceutical for each 
132 taxonomic group (PNECfish, PNECcrustaceans and PNECalgae) using the following prioritization 
133 and assessment factors diagram.
134
135 The assessment factor for chronic tests represents the transition from laboratory conditions 
136 to the field, with an additional factor applied for the conversion of the acute test to chronic 
137 levels. When no acute or chronic tests were available, the more sensitive test of genotoxicity 
138 was used with no assessment factor implementation. In the rare case where no experimental 
139 value was available, the toxicity calculation used by the Ecological Structure–Activity 
140 Relationship model (ECOSAR) was used and regarded as an acute toxicity value. PNEC values 
141 determined for 16 out the 19 analyzed pharmaceuticals, with indications of data origin and the 
142 applied factors, are presented in Table 1. 
143 The PNECs were then used along with the measured concentration data to estimate RQs 
144 for the mixture for the separate taxonomic groups using Equation 2:
145 (2)𝑅𝑄𝑡𝑔= [∑16𝑖= 1( 𝑀𝐶𝑖𝑃𝑁𝐸𝐶𝑖,𝑡𝑔)
146 where RQtg is the pharmaceutical risk quotient for a specific taxonomic group tg, MCi is the 
147 measured concentration of pharmaceutical i in the sample, and PNECi,tg is the PNEC of 
148 pharmaceutical i for taxonomic group tg.
149
150
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151 Table 1. Predicted no effect concentrations (PNEC; µg L-1) of the studied pharmaceuticals for 
152 the aquatic environment and for fish, crustaceans and algae taxonomic groups. Assessment 
153 factors are presented in Table S3.
Name Therapeutic activity Aquatic Fish Crustacean Algae
Carbamazepine 0.0526 250027 0.0526 0.228
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155 *Metabolite of Clofibrate.
156
157 RESULTS AND DISCUSSION
158 Our study focused on a typical micro-estuary in the Alexander Stream, which is in a semi-
159 arid Mediterranean climate zone and which drains a watershed of mixed land use (agricultural 
160 and municipal) that is highly influenced by treated wastewater11,23. Here we report data for 
161 base-flow and flood-event durations over 2 hydrological years (2016–17 and 2017–18) (Table 
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162 S4) which were within the normal annual flow-regime cycle based on measurements from 50 
163 years23. In addition to the temporal and spatial dynamics data for pharmaceuticals, our analysis 
164 evaluated ecosystem health by determining risk and its drivers.
165 Pharmaceutical occurrence and concentration: Estuary head and mouth 
166 All water samples collected at the head or mouth of the Alexander estuary during flood 
167 events or under base-flow conditions were contaminated with pharmaceuticals or their 
168 metabolites (Table 2). The five most frequently detected pharmaceuticals in the flood-event 
169 samples were carbamazepine, diclofenac, bezafibrate, caffeine, and sulfamethoxazole. Under 
170 base-flow conditions, the ubiquitous pharmaceuticals were carbamazepine, lamotrigine, 
171 bezafibrate, gemfibrozil, caffeine, and sulfamethoxazole. These occurrence patterns are similar 
172 to those in European rivers, where carbamazepine, diclofenac, caffeine, and sulfamethoxazole 
173 are highly ubiquitous53. 
174 Noticeable differences in substances in the base-flow and flood conditions were found. For 
175 example, ibuprofen was detected in ~90% of the flood-event samples but in only 27% of the 
176 base-flow sample. In contract, lorazepam was detected in only ~20% of flood-event samples 
177 compared to ~80% in the base-flow samples. Changes between flow conditions were also 
178 pronounced in terms of concentrations of pharmaceutical groups (Table 2). Anticonvulsants, 
179 sulfonamides, and the erectile dysfunction drug sildenafil exhibited higher average 
180 concentrations in base-flow samples than in the flood-event samples. Anti-inflammatories, 
181 lipid regulators, the stimulant caffeine, and the β-blocker metoprolol showed the opposite trend 
182 with higher concentrations in the flood-event vs. base-flow samples. These clear differences 
183 suggest a dominant influence of pharmaceuticals' environmental stability on their transport 
184 dynamics in the stream. The less environmentally persistence anti-inflammatories and caffeine 
185 (as calculated by Aminot et al. based on DT50 values54) are rapidly degraded in wastewater-
186 treatment plants and are therefore present at low concentrations under base-flow conditions. 
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187 The more environmentally persistence pharmaceuticals, such as anticonvulsants54, are found 
188 in relatively high concentrations under both base-flow and flood conditions.
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189 Table 2. Occurrence (%) and concentration (ng L-1) of pharmaceuticals and their metabolites in water samples collected from the head and mouth 
190 of the Alexander micro-estuary during flood Events (2016-17 and 2017-18; n = 236) and base flow (2017 and 2018; n = 44). 
 Floods events Base-flow
Occurrence Average Median Max Min Occurrence Average Median Max Min
Carbamazepine 100 414 180 4,953 25 100 643 644 1,947 52
Epoxy carbamazepine 100 28 15 294 1 98 57 60 179 0
trans-Dihydroxy carbamazepine 100 425 162 3,857 19 100 1,233 1,125 3,458 68
Lamotrigine 97 30 14 235 0 100 111 113 235 9
Lamotrigine-N-oxide 17 0.3 0 7 0 18 1 0 9 0
Acetaminophen 39 152 0 2,127 0 18 12 0 184 0
Diclofenac 100 126 77 730 0 80 99 46 692 0
Ibuprofen 89 297 172 3,291 0 27 71 0 592 0
Ketoprofen 60 20 17 158 0 41 9 0 34 0
Naproxen 17 40 0 1,146 0 34 25 0 174 0
Metoprolol 82 7 2 1,038 0 66 5 2 77 0
Sildenafil 51 3 1 179 0 82 10 6 139 0
Clofibric acid 60 148 17 11,765 0 41 5 0 36 0
Bezafibrate 100 94 66 1,041 5 91 39 18 248 0
Gemfibrozil 83 263 22 4,428 0 91 140 27 2,704 0
Lorazepam 19 0.4 0 4 0 77 2 2 4 0
Caffeine 100 2,859 2,746 12,969 19 100 828 60 11,559 11
Sulfamethoxazole 100 51 14 656 0 100 115 82 656 1
Sulfapyridine 98 10 4 133 0 89 11 7 87 0
191
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192 Overall, pharmaceutical concentrations found in the Alexander estuary were comparable to 
193 those found in other surface-water bodies, with a slight tendency toward the upper end of the 
194 concentration ranges2,53. Further comparison to other estuarine environments was performed 
195 using the German Environmental Agency pharmaceuticals in the environment database55. A 
196 total of 336 entries of mean and maximum values for 12 pharmaceuticals derived from 16 
197 countries were considered. Average concentration of pharmaceuticals in the Alexander micro-
198 estuary was on average ~7 folds higher than compiled entries from the database with 
199 metoprolol being the only compound showing a lower average concentration in the Alexander 
200 estuary compared to other estuarine systems (Table S5). 
201 The average pharmaceuticals cumulative concentration at the estuary head was slightly 
202 higher during flood events, with 5 µg L-1 compared to 4 µg L-1 under base-flow conditions 
203 (Figure 1). These findings contradict the assumption that dilution of the base-flow water, 
204 dominated by treated wastewater, by stormwater runoff significantly reduces the overall 
205 pharmaceutical concentration in flood events. Our findings suggest that pharmaceuticals in 
206 runoff events originate from another source, perhaps the urbanized part of the watershed. The 
207 increased concentrations of rapidly degradable compounds such as ibuprofen and caffeine 
208 during flood events support the assumption of an urban influence, suggesting sewage overflow 
209 mixed with urban runoff as a source for pharmaceuticals in the stream and estuary.
210 Within-season dynamics were also observed during the rainy season, where the highest 
211 concentration peaks (18.6–17 µg L-1) were recorded at the estuary head during the first flood 
212 event for each year (F2016-17 #1, F2017-18 #1; Figure 1). The peak concentration for F2016-
213 17 #1 was dominated by caffeine (41%) and anticonvulsants (29%), whereas the two 
214 consecutive peaks of F2017-18 #1 were composed mainly of caffeine (76% and 67%). We 
215 assume that cumulative concentration peaks at the beginning of a rainy season are attributed to 
216 the flushing of pharmaceuticals accumulated in bed sediments and pore water in the upper 
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217 tributaries during the wastewater base flow of the dry season. Although dilution had little 
218 influence on overall dynamics, high-discharge flood events (e.g., F2018 #4) exhibited a 
219 significant dilution effect resulting in low accumulation of pharmaceutical concentrations. 
220 Under base-flow conditions, pharmaceutical concentrations were dominated by the 
221 anticonvulsant carbamazepine and its metabolites. In general, the cumulative base-flow 
222 concentrations were lower than those of the flood events with one exception, the sample 
223 collected on 7 March 2018, which contained elevated concentrations of caffeine and anti-
224 inflammatories (Figure 1). This rise in concentration was composed mainly of caffeine (~12 
225 µg L-1) and ibuprofen (~1 µg L-1), probably from a recorded malfunction in the sewage-
226 treatment facility upstream. The malfunction resulted in approximately 2 weeks of raw sewage 
227 being spilled into an upper tributary, carrying the more degradable compounds into the estuary 
228 and elevating the cumulative pharmaceuticals concentration. On the other hand, a sharp drop 
229 in cumulative concentrations in the estuary head was observed during the dry season of 2018. 
230 At that time, the base flow was redirected from the stream for irrigation, lowering the annual 
231 median to 2.3 µg L-1, in comparison to 3.7 µg L-1 in 2017. The vast changes in pharmaceutical 
232 concentrations and mixture composition from sewage spills during base flow and sewage 
233 overflow during the rainy season, and on the other hand, from redirection of reclaimed 
234 wastewater for irrigation, emphasize the lack of a proper watershed-management effect on 
235 estuarine and coastal environmental pollution.
236 While flow types dictate the composition and concentration of pharmaceutical mixtures 
237 entering the estuary, the conditions in the estuary may influence the overall pharmaceutical 
238 concentration, and more importantly, cause shifts in pharmaceutical mixture composition. 
239 During flood events, cumulative pharmaceuticals concentration was generally lower in the 
240 estuary mouth vs. head. As an example, the peak concentration of the F2016-17 #1 event 
241 decreased by >20% along its flow in the estuary to 14.3 µg L-1 at the mouth (Figures 1 and 2). 
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242 Although the total contribution of anticonvulsants and caffeine to the cumulative concentration 
243 was maintained, the proportion of caffeine decreased from 41% to 28%, while that of the 
244 anticonvulsants increased from 29% to 44%. In the case of the F2017-18 #1 event, mouth 
245 samples were not collected since discharge was very low (Table S4), and the flood water was 
246 contained in the estuary and strongly diluted by the base flow and seawater intrusion. 
247 The estuary water body holds ~300,000 m3 over a length of 6.5 km, resulting in long-
248 duration replacement of base-flow water with storm water. This enables the estuary to hold on 
249 to low water volumes, associated with small flood events, prolonging their residence time. The 
250 effect is on the scale of complete retention in the estuary, such as for F2017-18 #1, to hours, 
251 e.g., F2016-17 #1 where the first flood wave entering the estuary arrived at its mouth after 10 
252 h. Therefore, the presence of a base-flow signature of pharmaceutical mixture composition is 
253 highly pronounced in the first flood-event outflow samples. In general, an increased 
254 contribution of anticonvulsants and lipid regulators to the cumulative pharmaceuticals 
255 concentration was recorded in outflux samples of all flood events (Figures 1 and 2).
256 A reduction in pharmaceutical concentration was observed under base-flow conditions 
257 along the flow in the estuary, where anticonvulsant concentrations dropped by ~25% from head 
258 to mouth during the 2017 base flow. Reduction was also pronounced in a spring 2018 water 
259 sample where the elevated caffeine concentrations dropped by almost 50%. Pharmaceutical 
260 addition and removal along the estuary under the different flow conditions are complex and 
261 derive from the dynamics between the multiple sources, the compound characteristics and 
262 persistence, and sorption–desorption processes. These changes may influence the risk potential 




Page 14 of 33
ACS Paragon Plus Environment
Environmental Science & Technology
267 Ecotoxicological risks: Single compound approach 
268 Due to dilution cycles, continuous changes in geochemical conditions, and the diverse 
269 exposed taxonomic groups, there is a need for a dynamic ecological risk evaluation. We 
270 focused our efforts on the changes in risk between the head and mouth of the estuary under 
271 different flow conditions (Figure 3). Under base flow conditions, at the head of the estuary, 
272 carbamazepine and diclofenac were found to pose an unacceptable risk, with median RQ of 
273 ~15 and ~ 1 respectively. Sildenafil and lorazepam had median RQ values of 0.3 and 0.5, 
274 respectively, posing minor risk. All other compounds exhibited median RQ values < 0.1 
275 indicating an acceptable risk. Carbamazepine risk was also found to pose an unacceptable risk 
276 at the head of the estuary during flood-events, with a median RQ of 2.5, under these conditions 
277 ibuprofen and caffeine were also found to pose an unacceptable risk with median RQs of ~18 
278 and ~3, respectively. Diclofenac and acetaminophen also showed RQ values higher than 1 on 
279 several occasions. Our data show that flood risk is driven by more readily degradable, but still 
280 toxic, compounds into the estuary that are otherwise absent from the system. Moreover, flood 
281 water eventually replaces the estuarine volume to become background water, dominating the 
282 habitat for weeks, and imposing elevated risk during the rainy season. 
283 Under the base-flow regime, risk quotients for the estuary outflow were lower than for the 
284 head of the estuary. Median RQ values for carbamazepine and diclofenac were reduced from 
285 15 to 10 and from 1 to 0.1, respectively (Figure 3). These drops in RQ may be the consequence 
286 of dissipation processes in the estuary due to prolonged water residence time under base-flow 
287 conditions. For some pharmaceuticals, RQ values in the outflow during flood events were also 
288 reduced compared to the head with the estuary with drops of 10% and 30% was observed for 
289 ibuprofen and caffeine in outflow samples. On the other hand, an increase in median RQs was 
290 observed for carbamazepine and gemfibrozil, from 2.5 and 0.01 to 7 and 0.6, respectively. 
291 These increases in relatively environmentally stable pharmaceuticals suggest additional 
Page 15 of 33
ACS Paragon Plus Environment
Environmental Science & Technology
292 sources of treated wastewater along the flow in the estuary, and perhaps, resuspension and 
293 desorption processes in the estuary. These changes show that the risk regime expands beyond 
294 temporal variations to spatial location along the estuarine flow, and reflects the complex 
295 dynamics of pharmaceutical mixtures transported through the estuary. 
296
297 Ecotoxicological risks: Analysis per taxonomic groups 
298 While single-compound risk is crucial to identifying key stressors, the estuarine 
299 environment is exposed to multiple pharmaceuticals which may affect each taxonomic group 
300 differently. Furthermore, use of the concentration addition model to estimate cumulative risk 
301 enables targeting risk assessments to specific taxonomic groups, such as fish, crustaceans and 
302 algae (Figure 4). The overall annual RQ medians at the head of the estuary for fish, crustaceans 
303 and algae were 20, 3.5 and 4.5, respectively. For fish, median RQ values for flood events was 
304 ~22 vs. only 4.5 under base-flow conditions (Figure 4). Risk for crustaceans was elevated in 
305 the base flow with median RQ values of ~11 compared to 3.5 in the flood events. For algae, 
306 the RQ values for the flood and base flow conditions were relatively similar (4.5 and 3.5, 
307 respectively). Only 3 inflow water samples (out of 151), collected from the base flow during 
308 the peak dry season of 2018, exhibited RQ values lower than 1 (i.e., no risk) for fish (Figure 
309 S2). For crustaceans, 11 samples (collected at the end of F2017 #3 and beginning of F2017 #4 
310 events) showed RQ values lower than 1; and 10 samples exhibited no risk for algae, mainly 
311 samples from F2017 #4 at peak discharge and the base flow in the 2018 dry season. 
312 The highest RQ values of 338 and 227 were calculated for fish during the second and third 
313 flood events of 2016 (F2016-17 #2 and #3), in agreement with its elevated median RQ in flood 
314 events (Figure 4 and S2). Although the median RQ for crustaceans was higher during base 
315 flow, peak RQ values of 32 and 27 were measured at the beginning of the first flood event of 
316 each of the rainy seasons, suggesting first season wash of the upper watershed. Similar to 
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317 crustaceans, the RQ for algae peaked at 16 and 19 at the beginning of the first two flood events 
318 of each of the rainy seasons. 
319 The anti-inflammatory ibuprofen, which was less dominant in terms of concentration 
320 (Figures 1 and 2), was the compound found to contribute most to the RQ for fish, (Figure S2). 
321 Yet even in the absence of ibuprofen, 95% of the water samples showed unacceptable risk to 
322 fish with RQ values higher than 1. In these samples, risk was mainly derived from the lipid 
323 regulator bezafibrate and the anti-inflammatory diclofenac. Risk for crustaceans was derived 
324 almost entirely from the anticonvulsant drug carbamazepine, in both flood events and base 
325 flow, with a small contribution from the stimulant caffeine. An additional contribution to risk 
326 for crustaceans was the lipid regulator metabolite clofibric acid. Unlike risk to fish, removal of 
327 the dominant contributor (i.e., carbamazepine) from the cumulative risk calculation for 
328 crustaceans resulted in only ~20% of the samples exceeding an RQ value of 1. Risk to algae 
329 was mostly driven by the stimulant caffeine, contributing 56% of the risk on average, followed 
330 by carbamazepine, responsible for 30% of the RQ, mainly during base flow (Figure S2). Minor 
331 contributions to risk for algae were from ibuprofen and sulfamethoxazole. Omitting both 
332 caffeine and carbamazepine from the cumulative risk calculations for algae still resulted in 
333 ~25% of the samples exceeding an RQ of 1, all from flood events.  
334 The overall median RQ values for estuary mouth samples were relatively similar to those 
335 for the head samples (Figure 4). The most pronounced difference in risk to crustaceans was 
336 found during flood events, being over twofold higher in mouth vs. head samples, with a median 
337 RQ of ~8. Median RQ for algae during flood events was slightly higher in the outflow (5.5), 
338 even though the dominant toxicant, caffeine, had decreased in concentration (Figures 1 and 2). 
339 This additive effect was due to the increase in carbamazepine concentration, which was also 
340 found to be a main contributor of risk to algae (Figures S2 and S3). The same trend was found 
341 for cumulative risk to fish during flood events, being slightly elevated in outflow samples with 
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342 a median RQ of 23 (Figure 4). The reduction in ibuprofen concentration was substituted by the 
343 elevation in gemfibrozil concentration and risk to fish. Base-flow conditions at the mouth of 
344 the estuary were similar to those at the estuary head, where the biggest recorded difference was 
345 a decrease of 25% median RQ for fish. It is important to note that the elevated risk to algae 
346 from caffeine, due to the sewage spill in March 2018, dropped by almost 50% from head to 
347 mouth (Figures S2 and S3). The observed removal emphasizes the strong dissipation processes 
348 that might occur along the estuary under long water residence times.
349
350 Ecotoxicological risks: Effects of geochemical conditions 
351 Although geochemical factors were not included in our risk calculation, they can affect 
352 directly or indirectly the ecological risk in micro-estuaries. Temperature in the micro-estuary 
353 ranges between 15-30 °C, peaks in the dry season when treated wastewater flows dominates 
354 the system (Figure S4). Temperature rise in dry season (i.e., base flow condition) is expected 
355 to pose abiotic stress via reducing the level of dissolved oxygen. In practice, the highly nutrient 
356 loaded wastewater induces eutrophication processes resulting in sever oxygen deficiency 
357 throughout the micro-estuary water column (Figure S4). The continuous anoxic-hypoxic 
358 conditions, which may be harmful for aquatic organisms on its own, along with low rates of 
359 water replacement11, and possibly reduced microbial degradation of pharmaceuticals under 
360 these conditions56, may result with elevated stress to the aquatic habitat during the dry season.
361 The reactivity of pharmaceuticals might be also affected by geochemical conditions, and in 
362 turn, influence the ecological risk. In micro-estuaries, pharmaceuticals are exposed to rising 
363 levels of salinity along the flow and with depth of the water column (Figure S4). This may 
364 affect the potential calculated toxicity of compounds to some extent52,57,58. Yet salinity may 
365 more profoundly affect pharmaceuticals risk indirectly, due to alteration of sediment-water 
366 partitioning. Elevated salinity is expected to increase adsorption of organic pollutants, reducing 
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367 the concentration in water column (and lowering the risk to organisms within that media), but 
368 increasing the concentration in bed sediments and the resulted risk to benthic dwellers. 
369 However, these effects are more pronounced for hydrophobic compounds rather than to the 
370 studied pharmaceuticals exhibiting low log D (Table S1). 
371
372 Environmental implications 
373 Estuarine environments, such as the Alexander stream, are continuously exposed to organic 
374 pollutants59, among them biologically active pharmaceuticals3,23,53.  Pharmaceuticals are 
375 introduced to estuarine habitats via runoff from rural and municipal zones during the rainy 
376 season. During the long and dry summer periods, pharmaceuticals are introduced via 
377 wastewater which made up the sole water source for these ecosystems. The composition of the 
378 pharmaceutical mixtures is highly coupled to the flow patterns, thus exposing the estuary to a 
379 changing risk regime. 
380 The use of general PNECaquatic and RQ as risk parameters is of great value in locating 
381 dominant drivers, but the use of taxonomic group PNECs allowed a more practical risk 
382 assessment, especially in systems with fluctuating flow conditions. While general aquatic risk 
383 showed elevated risk from caffeine during flood events, in practice, caffeine risk peaked at the 
384 beginning of the flood events and mainly affected algae, which are most likely washed from 
385 the system during this flood stage. On the other hand, ibuprofen is mostly toxic to fish, which 
386 stays within the estuary. Nevertheless, risk to algae extends beyond the flood's first wave and 
387 remains a concern as these primary producers are extremely important to micro-estuaries, 
388 dictating the oxygen balance in these highly eutrophicated ecosystems. 
389 Ibuprofen, carbamazepine and caffeine were the main compounds contributing to risk for 
390 different taxonomic groups. However, their removal from the system is not expected to fully 
391 mitigate the ecosystem, as the level of the mixture's risk remains high. Caffeine and ibuprofen 
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392 originate mainly from raw or semi-treated wastewater and can be controlled by preventing 
393 sewage spills and overflows. Carbamazepine, on the other hand, is diffusive and more 
394 persistent, and its removal from the system is more challenging. Along with lipid regulators 
395 and sulfonamides, removing carbamazepine's adverse effect requires the complete removal of 
396 treated wastewater from the stream flow, and therefore must include control of the arable land 
397 runoff from fields irrigated with treated wastewater. The latter is of high importance since flood 
398 tails water, posing potential risk to algae and elevated risk to fish, enters the estuary in flow 
399 with decreasing velocities, eventually acquiring base-flow residence times of ~20 days. 
400 The Alexander micro-estuary is exposed annually to chronic risk throughout its entire 
401 length and under the different flow conditions. This reflects the high potential risk in 
402 hypereutrophic micro-estuaries to several taxonomic groups from a mixture of pharmaceuticals 
403 originating from both point and diffuse pollution sources. The current work findings highlight 
404 the need to update water regulations, which do not currently take pharmaceutical mixtures into 
405 account. Furthermore, watershed-management interfaces are required in semi-arid region 
406 streams and estuaries to reduce pharmaceutical influx and prolong water residence time, 
407 thereby enhancing the natural removal processes. 
408
409 Supporting Information 
410 Information is provided about internal standards used for LC-HRMS; selected 
411 pharmaceuticals properties and analytical method parameters (Table S1). Assessment factors 
412 determination for PNECaquatic are provided in Table S2 and pharmaceuticals assessment factors 
413 and PNECs are presented in Table S3. Sampled flow events characteristics are listed in Table 
414 S4. A map of the study site is shown in Figure S1. Risk quotient distribution between 
415 pharmaceuticals during 2 hydrological years is presented in Figures S2 and S3. Geochemical 
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416 conditions in the Alexander micro-estuary in the two-years study duration are shown in Figure 
417 S4. These materials are available free of charge via the Internet at http://pubs.acs.org/.
418
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626
627 Figure 1. Concentrations of groups of pharmaceuticals (left axis) and flow discharges (right axis) during 2 hydrological years (Table 2) measured 
628 at the head of the Alexander micro-estuary. Horizontal axis presents water samples in chronological order, where F represents flood events and 
629 BF represents base flow.
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631
632 Figure 2. Concentrations of groups of pharmaceuticals (left axis) and flow discharges (right axis) during 2 hydrological years (Table 2) measured 
633 at the mouth of the Alexander micro-estuary. Horizontal axis presents water samples in chronological order, where F represents flood events and 
634 BF represents base flow.
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637 Figure 3. Pharmaceutical risks in flood and base-flow water samples collected at the head and 
638 mouth of the Alexander micro-estuary. Risk quotients were calculated using point of no effect 
639 concentrations for the aquatic habitat (PNECaquatic).
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642 Figure 4. Cumulative pharmaceutical risk in the Alexander micro-estuary. A risk quotient of 
643 1 (red line) marks toxicity benchmarks (Table 1). Cumulative pharmaceutical risk to fish, 
644 crustaceans and algae at the head of the estuary (solid, n = 151) and mouth of the estuary 
645 (diagonal stripes, n = 130). Exceptional samples from head (7) and mouth (9) samples in flood 
646 events, with risk quotients ranging from 100 to 338 for fish, were omitted.
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